Wolters Kluwer N V Stock Price, News & Analysis

Wolters Kluwer Legal & Regulatory has successfully completed its acquisition of Brightflag, a global provider of legal spend and matter management software. The completion follows the initial agreement announcement made on May 29, 2025. Brightflag's software solutions specialize in legal spend management and matter management, complementing Wolters Kluwer's legal technology portfolio. The acquisition marks a strategic move by Wolters Kluwer to strengthen its position in the legal technology sector.

Wolters Kluwer (WTKWY) reports the repurchase of 225,452 ordinary shares between May 29-June 4, 2025, at an average price of €155.93, totaling €35.2 million. This is part of a larger €1 billion share buyback program announced on February 26, 2025. Year-to-date, the company has repurchased 2,750,306 shares for €427.5 million at an average price of €155.43. The company has engaged third parties to execute €350 million in buybacks from May 8 to July 28, 2025. The repurchased shares will be held as treasury shares and eventually canceled for capital reduction purposes.

Wolters Kluwer Health has acquired IntelliLearn Pty Ltd., an Australian provider of online courseware solutions for nursing schools. Founded in 2010 in Adelaide, IntelliLearn offers cloud-based training modules focused on medication safety and medical math content for educational institutions across Australia, New Zealand, Canada, and the U.S. The acquisition brings seven full-time employees and a network of contract workers to Wolters Kluwer. IntelliLearn will be integrated into Wolters Kluwer's Health, Learning, Research & Practice business unit, complementing their Lippincott nursing education portfolio. The deal is expected to achieve return on invested capital above the company's weighted after-tax cost of capital within 3-5 years, with minimal impact on adjusted earnings.

Wolters Kluwer (WTKWY) has appointed Greg Samios as the new CEO of its Health division, effective June 1, 2025. Samios, who brings over 25 years of healthcare experience, succeeds Stacey Caywood, who became a Member of the Executive Board on May 15, 2025.

As Executive Vice President of the Health division's largest business units, Samios has led growth in clinical decision support products like UpToDate and Medi-Span. He spearheaded the integration of generative AI into healthcare products and strengthened partnerships with digital health companies. His previous roles include Executive VP of Legal & Regulatory U.S. at Wolters Kluwer and health-focused positions at Elsevier.

Wolters Kluwer (WTKWY) has reported its latest share buyback transactions for the period of May 22-28, 2025. The company repurchased 226,259 ordinary shares at an average price of €160.75, totaling €36.4 million. This is part of a larger €1 billion share buyback program announced on February 26, 2025.

Year-to-date, Wolters Kluwer has repurchased 2,524,854 shares for a total consideration of €392.3 million at an average price of €155.38. The company has engaged third parties to execute €350 million of buybacks between May 8 and July 28, 2025. The repurchased shares will be held as treasury shares and eventually canceled for capital reduction purposes.

Wolters Kluwer Legal & Regulatory has agreed to acquire Brightflag, an AI-powered legal software company, for €425 million in cash. Brightflag, founded in 2014, specializes in cloud-based legal spend and matter management software, with 155 employees joining Wolters Kluwer post-acquisition. The company demonstrated strong growth with a 36% revenue increase in 2024, reaching €22 million, and €27 million in annual recurring revenue by April 2025. Notably, 95% of Brightflag's revenue is recurring, with 60% coming from U.S. customers. The acquisition aims to strengthen Wolters Kluwer's presence in mid-size corporations across the U.S. and Europe, complementing their existing focus on large corporations. The deal is expected to close in June 2025.

Wolters Kluwer (WTKWY) has reported the latest transactions in its ongoing share buyback program. From May 15-21, 2025, the company repurchased 211,173 ordinary shares at an average price of €159.50, totaling €33.7 million. This is part of a larger €1 billion share buyback program announced on February 26, 2025. Year-to-date, the company has repurchased 2,298,595 shares for €355.9 million at an average price of €154.85. The company has engaged third parties to execute €350 million of buybacks between May 8 and July 28, 2025. The repurchased shares will be held as treasury shares and eventually canceled for capital reduction purposes.

Wolters Kluwer's 2025 Annual General Meeting (AGM) saw the adoption of all proposed resolutions. Key highlights include: Stacey Caywood's appointment to the Executive Board, with plans to make her CEO and Chair following Nancy McKinstry's retirement in February 2026. Kevin Entricken was reappointed as CFO for four years, while Ann Ziegler was reappointed to the Supervisory Board for two years. Shareholders approved the 2024 Financial Statements and a total dividend of €2.33 per share, with a final dividend of €1.50 payable in June 2025. KPMG was appointed as external auditor for sustainability statements (2025-2028). The meeting had a 76.69% shareholder representation and approved the Executive Board remuneration policy update.

Wolters Kluwer (WTKWY) has reported details of its ongoing share buyback program for the period of May 8-14, 2025. The company repurchased 225,090 ordinary shares at an average price of €157.13, totaling €35.4 million. This is part of a larger €1 billion share buyback program announced on February 26, 2025.

Year-to-date, Wolters Kluwer has repurchased 2,087,422 shares for a total consideration of €322.3 million at an average price of €154.38. The company has engaged third parties to execute €350 million of buybacks between May 8 and July 28, 2025. The repurchased shares will be held as treasury shares and eventually canceled for capital reduction purposes.